FIELD TESTS, MODEL VALIDATION AND PERFORMANCE OF A CO2 COMMERCIAL REFRIGERATION PLANT INTEGRATED WITH HVAC SYSTEM

A fully instrumented CO2 trans-critical booster system with parallel compression, in operation in a small size supermarket in northern Italy, made available measured data that allowed monitoring its performance. The entire refrigeration system of the supermarket, i.e. the Commercial Refrigerating Unit, the refrigerated display cabinets and cold rooms, have been modelled in TRNSYS with in-house types for all components. The comparison with the field data available from monitoring the plant allowed to thoroughly calibrate the model, spanning the operation conditions of a whole year. The validated model is a reliable and powerful tool, usable to predict the plant performance in several conditions and to evaluate the feasibility and effectiveness of the integration with DHW/HVAC systems. Measurements and simulations show that, at mild climate conditions, it is possible and effective to fully provide HVAC and refrigeration duties with a single all-in-one unit properly designed and operated

Transcritical CO2 commercial refrigeration plant with adiabatic gas cooler and subcooling via HVAC: field tests and modelling

Subcooling methods at the exit of the gas cooler in transcritical CO2 commercial refrigeration systems have been studied in the recent years showing that overall remarkable improvements can be obtained. Another strategy that results efficient is the use of evaporative systems at the gas cooler (adiabatic cooling) as it allows to significantly reduce the refrigerant quality at the liquid receiver and to lower the heat rejection pressure. In this work, a fully instrumented CO2 transcritical booster system with parallel compression, in operation in a small size supermarket in northern Italy, made available measured data of its performance when subcooling and/or adiabatic cooling are active. The plant operates in a mild climate, where it suffers operation at transcritical conditions for most of the year. Subcooling in this plant is performed by coupling the refrigeration system with the HVAC system. Taking advantage of experimental measurements, a model in the TRNSYS environment is validated and allows the prediction of the annual plant performance when these strategies are adopted. The adiabatic cooling showed to allow a significant reduction (about 10%) in the energy use, and makes unnecessary the use of a parallel compressor. Subcooling by the HVAC gives rise to a reduced saving (2.9 %) due to the absence of a dedicated mechanical subcooler, however it is almost comparable to parallel compression. These trends are confirmed in two other hot and humid climates

Effect of dedicated mechanical subcooler size and gas cooler pressure control on transcritical CO2 booster systems

Dedicated Mechanical Subcooling (DMS) is one of the most investigated and effective strategies applied to increase the performance of CO2 commercial refrigeration systems in transcritical operation. Further performance benefits can be obtained by a reduction of the gas cooler pressure of the main cycle at transcritical conditions. In this work the most important parameters for the design and operation of such a system, i.e. the DMS cooling capacity, the subcooling degree and the gas cooler pressure, are considered and their effect on the annual energy use of the plant is estimated in warm and hot climate conditions by means of a validated model. DMS is also compared to the parallel compression scheme and subcooling performed through a water chiller dedicated to HVAC. DMS results to be the most effective solution among those investigated, and the choice of the best design and operating parameters allows further energy saving and cost reduction

Varroa destructor exacerbates the negative effect of cold contributing to honey bee mortality

Several concurrent stress factors can impact honey bee health and colony stability. Although a satisfactory knowledge of the effect of almost every single factor is now available, a mechanistic understanding of the many possible interactions between stressors is still largely lacking. Here we studied, both at the individual and colony level, how honey bees are affected by concurrent exposure to cold and parasitic infection. We found that the parasitic mite Varroa destructor, further than increasing the natural mortality of bees, can induce an anorexia that reduces their capacity to thermoregulate and thus react to sub-optimal temperatures. This, in turn, could affect the collective response of the bee colony to cold temperatures aggravating the effect already observed at the individual level. These results highlight the important role that biotic factors can have by shaping the response to abiotic factors and the strategic need to consider the potential interactions between stressors at all levels of the biological organization to better understand their impact

The burden of severe cases of Influenza disease: The Friuli Venezia Giulia Region experience

IIntroduction. Influenza is a matter of serious concern for clinicians, in both outpatient and in-hospital settings. Worldwide, the 2017-18 epidemic proved to be the most severe since 2003-04. We report a real-world experience regarding the management of patients with influenza admitted to a large teaching hospital in the Friuli Venezia Giulia region during the 2017-2018 influenza season. We also provide a practical guide for the management of hospitalized influenza patients. Methods. A retrospective observational analysis was conducted among all influenza patients requiring admission to our center during the 2017-18 season. Results. Overall, 29 patients were admitted to the University Hospital of Udine during the 2017-18 season with a diagnosis of influenza. B virus was responsible for the majority of cases. More than 65.5% of the subjects presented with a complication. We estimated that 41.4% of the patients admitted were affected by a \u201csevere form\u201d. All these cases required admission to the Intensive Care Unit, with 27.6% and 10.3% needing Orotracheal Intubation and Extracorporeal Membrane Oxygenation, respectively. The fatality rate was 24.1%. Notably, only 9 subjects in our cohort had been vaccinated. Based on the experience acquired during the past season, we propose a practical guide to the management of influenza cases in everyday hospital practice. Conclusion. The cornerstones of the management of all hospitalized influenza patients are the rapid identification and treatment of severe forms. Timely and strict adherence to contact and respiratory precautions are also fundamental to reducing the risk of intra-hospital outbreaks. Despite improvements in antiviral therapies and supportive measures, influenza-related morbidity and mortality remain high. In our opinion, a universal vaccination program is the only safe and effective method of filling the gap

COVID-19 outbreak in healthcare workers in hospitals in Trieste, North-east Italy

N/

Measles in Italy: Viral strains and crossing borders

In 2017, Italy experienced one of the largest outbreaks of measles in recent years, with 5404 notified cases and 4347 confirmed cases. A further 2029 cases were notified during the first 6 months of 2018, and 1516 of them were laboratory-confirmed. The B3 and D8 genotypes were identified as those responsible for the outbreak. Possible transmission routes can be established by monitoring the circulating measles virus strains in support of the national health authorities to warn people and travellers

Tick-borne encephalitis in north-east Italy: a 14-year retrospective study, January 2000 to December 2013

Italy is considered at low incidence of tick-borne encephalitis (TBE), and the occurrence of human cases of TBE appears to be geographically restricted to the north east of the country. However, most information to date derives from case series, with no systematic data collection. To estimate incidence rates (IR) and spatial distribution of TBE cases, we conducted a retrospective study in north-eastern Italy. Data were collected through the infectious disease units and public health districts of three regions (Friuli Venezia Giulia, Trentino Alto Adige and Veneto) between 2000 and 2013. Overall, 367 cases were identified (IR: 0.38/100,000). The cases' median age was 56 years and 257 (70%) were male. Central nervous system involvement was reported in 307 cases (84%). Annual fluctuations in case numbers occurred, with peaks in 2006 and in 2013, when 44 and 42 cases were respectively observed. A strong seasonality effect was noted, with the highest number of cases in July. In terms of geographical location, three main endemic foci with high TBE IR (> 10/100,000) were identified in three provinces, namely Belluno (Veneto region), Udine (Friuli Venezia Giulia) and Trento (Trentino Alto-Adige). When investigating the whole study area in terms of altitude, the IR between 400 and 600\u2009m was greater (2.41/100,000) than at other altitudes (p< 0.01). In conclusion, the incidence of TBE in Italy is relatively low, even considering only the three known affected regions. However, three endemic foci at high risk were identified. In these areas, where the risk of TBEV infection is likely high, more active offer of TBE vaccination could be considere

Has VZV epidemiology changed in Italy? Results of a seroprevalence study

The aim of the study was to evaluate if and how varicella prevalence has changed in Italy. In particular a seroprevalence study was performed, comparing it to similar surveys conducted in pre-immunization era. During 2013–2014, sera obtained from blood samples taken for diagnostic purposes or routine investigations were collected in collaboration with at least one laboratory/center for each region, following the approval of the Ethics Committee. Data were stratified by sex and age. All samples were processed in a national reference laboratory by an immunoassay with high sensitivity and specificity. Statutory notifications, national hospital discharge database and mortality data related to VZV infection were analyzed as well. A total of 3707 sera were collected and tested. In the studied period both incidence and hospitalization rates decreased and about 5 deaths per year have been registered. The seroprevalence decreased in the first year of life in subjects passively protected by their mother, followed by an increase in the following age classes. The overall antibody prevalence was 84%. The comparison with surveys conducted with the same methodology in 1996–1997 and 2003–2004 showed significant differences in age groups 1–19&nbsp;y. The study confirms that in Italy VZV infection typically occurs in children. The impact of varicella on Italian population is changing. The comparison between studies performed in different periods shows a significant increase of seropositivity in age class 1–4&nbsp;years, expression of vaccine interventions already adopted in some regions

Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers

Reactivation of herpes simplex virus type 1 (HSV-1) has been described in critically ill patients with coronavirus disease 2019 (COVID-19) pneumonia. In the present two-center retrospective experience, we primarily aimed to assess the cumulative risk of HSV-1 reactivation detected on bronchoalveolar fluid (BALF) samples in invasively ventilated COVID-19 patients with worsening respiratory function. The secondary objectives were the identification of predictors for HSV-1 reactivation and the assessment of its possible prognostic impact. Overall, 41 patients met the study inclusion criteria, and 12/41 patients developed HSV-1 reactivation (29%). No independent predictors of HSV-1 reactivation were identified in the present study. No association was found between HSV-1 reactivation and mortality. Eleven out of 12 patients with HSV-1 reactivation received antiviral therapy with intravenous acyclovir. In conclusion, HSV-1 reactivation is frequently detected in intubated patients with COVID-19. An antiviral treatment in COVID-19 patients with HSV-1 reactivation and worsening respiratory function might be considered